Key Words: methylphenidate, hyperactivity, risk factors, population-based survey, ADHD E stimated to occur in 9% of boys and 3% of girls aged 4 to 16 years (1), ADHD is the most common psychiatric syndrome in children. While psychostimulants are documented as effective in controlling the overactivity, inattention, and impulsiveness typical of ADHD (2) , their use has been controversial (3) . The most common stimulant used is MPH (4) . ADHD and treatment with stimulant medications are more common among boys than among girls and among schoolaged children than among preschoolers or teenagers (5) (6) (7) (8) (9) (10) . Other correlates of stimulant use in population-based studies appear to reflect the child's context. For instance, urban residence has been associated with use in some (9) but not all (5) studies, and family income has been positively (9) , negatively (11), and not (5) associated with stimulant use. Variations in levels of stimulant use have been correlated with geography (5, 9, 11, 12) and prescriber characteristics (5, 8, 9, 11) . In some jurisdictions, a few physicians account for large numbers of prescriptions (5, 9) .
Identification and treatment of ADHD increased during the 1990s in the US (6, 8, 13) and in Canada (11) . Stimulant use appears to have increased among girls (8) , and the age of peak use has gone up (8) , as have prevalence rates of use, suggesting persistence of use into the teenage years.
The foregoing information regarding stimulant use has been obtained from large-scale administrative and prescription databases. These databases contain information recorded by health care providers and reflect physician diagnostic and prescribing practices. Databases such as these offer little information about parent and family characteristics that might influence use of medications for treatment of ADHD. Small-scale clinical studies identify psychosocial adversity such as family conflict, parent psychopathology, and low social class as common correlates of childhood ADHD (14) (15) (16) (17) (18) . Negative parent-child interactions have also been implicated in the etiology of ADHD in some (15, 19) , but not all (20) , studies. Clinical experience suggests that psychosocial adversity or poor parenting practices could interfere with obtaining medical treatment or adhering to treatment if it is prescribed. If this is so, then psychosocial adversity or poor parenting practices would be expected to lessen the likelihood that a child would use stimulants for ADHD. In addition, parents decide when to seek help from professionals, and only a minority of children who have ADHD receive specialized services from mental health agencies, social services, or special education programs (1) . For these reasons, investigating the contribution of parent and family factors to stimulant use in children is important in understanding which children receive treatment for ADHD.
The NLSCY is a large-scale, population-based database that collected information primarily from parents about their children. It offers an alternative data source to administrative and prescription databases for information regarding use of stimulant medications by Canadian children-one reflecting parent and family sources, not health care provider sources of information. An earlier report using the NLSCY noted that the prevalence of MPH use was less than 2% in 1994-1995 and increased by 36% in 1996-1997 (21) . Use was noted to be greater among boys than among girls and among those of school-age than among preschoolers. While MPH use was presumed to occur among children with ADHD, no behavioural characteristics of children or information about parents was investigated.
This study uses the NLSCY database to investigate psychosocial correlates of ADHD identified in clinical populations to see whether these characteristics are associated with MPH use in the nonclinical population. It tracks MPH use from 1994-1995 to 1998-1999 and investigates parent and child characteristics as correlates of stimulant use. It is hypothesized that boys of school age with high levels of hyperactivity and aggression will likely be the children using MPH, because these are common clinical correlates of children with ADHD (22, 23) . The secondary hypotheses are that parent and family characteristics associated clinically with ADHD, such as maternal depression, parental substance use, poor family functioning, and poor parenting skills, will also be associated with MPH use in children. It is anticipated that increases in stimulant use will occur over time among all age groups and both sexes.
Method
Using data from the NLSCY, we identified 3 cross-sectional cohorts of children aged 2 to 11 years in 1994-1995, 1995-1996, and 1998-1999 . We measured associations between child, parent, and family characteristics and parentreported MPH use. Information regarding correlates was collected by means of structured interviews in the child's home with the person most knowledgeable about the child-in 89.9% of cases, the biological mother. The initial data collection in 1994-1995 used a random sampling frame of Cycle 3 (1998 Cycle 3 ( -1999 . Overall response rates to the survey were 87%, 91%, and 88%, respectively.
Study Population
For each data collection, the subset of children aged 2 to 11 years whose parent answered the question "Does he/she take any of the following prescribed medications on a regular basis: Ritalin?" were included. The independent variables evaluated fell into 3 categories, sociodemographic, individual child, and parent or family factors.
Sociodemographics included urban or rural household, low maternal education (did not complete high school), low income adequacy, and single-parent status. Income adequacy was determined according to Statistics Canada's derived variable of household size and income. The 2 lowest categories were combined to indicate low income adequacy, a dichotomous grouping that corresponds closely to Canada's poverty lines in 1995 (24) .
Child characteristics included sex, age, and child behaviour. Age was subgrouped into preschool, age 2 to 5 years, and school age (6 to 11 years) to investigate potential increased use over time in the 2 age categories separately.
Child behaviour (hyperactivity and aggression) was measured as follows: Parent-reported descriptions of child hyperactivity and aggression were collected by means of the NLSCY Child Behaviour Scale (25) . Items with known psychometric properties from other large community-based surveys of children were used to develop this scale. Separate scales were used for children aged 2 to 3 years and for those aged 4 to 11 years. For the younger age group, principal components analysis identified 5 underlying factors; the following 2 subscales were used for this study: Hyperactivity-Inattention, with Cronbach's a = 0.80, and Physical Aggression-Opposition, with Cronbach's á = 0.75 (25) . For the children aged 4 to 11 years, principal components analysis identified 6 factors, of which 2 were used for this study: Hyperactivity-Inattention, with Cronbach's á = 0.84, and Physical Aggression-Conduct Disorder, with Cronbach's á = 0.77 (25) . After stratification by age in 2-year increments, as well as by sex, those children scoring > 1.5 SD above the mean were classified as positive for hyperactivity or positive for aggression on the corresponding scales.
Parent and family factors included family dysfunction, maternal depression, parenting style, parent smoking, and parent drinking.
Family Dysfunction. The 12-item General Functioning subscale of the McMaster Family Assessment Device is a reliable and valid measure of family functioning (26) previously used in large-scale community surveys (27) . Families scoring > 1.5 SD above the mean were identified as positive for dysfunction.
Maternal
Depression. An abbreviated version of the Centre for Epidemtiologic Studies Depression Scale Scale (28) was used to determine the frequency of maternal depressive symptoms. The full version has been previously used in large-scale community surveys (29) . The scale estimates the presence and severity of 12 items describing mood symptoms over the past week. Mothers scoring > 1.5 SD above the mean were identified as positive for depression. 
Statistical Analysis
Statistics Canada's data publication guides were followed throughout all analyses (25) . Data were weighted up to the population level according to weights derived by Statistics Canada for the purpose of cross-sectional analysis for each data collection. Corrections for the effect of sampling design on parameter estimates were produced with coefficients of variation derived by Statistics Canada. The prevalence of MPH use was estimated for preschoolers (aged 2 to 5 years) and school-aged children (aged 6 to 11 years) in each data collection. Chi-square was used to compare sample characteristics and the proportion of the sample with positive responses to question regarding MPH use at each data collection. The associations between potential correlates and MPH use for each data collection were also evaluated with chi-square. The following variables were included in the logistic regression models to be investigated as potential correlates of MPH use for each time point: child age, sex, low income adequacy, low maternal education, single-parent status, high level of child hyperactivity, high level of child aggression, presence of maternal depression, presence of family dysfunction, parental smoking, parental alcohol use, and 4 parenting style variables. Collinearity among the variables was investigated with correlation matrices. Backward selection procedure (with P value to stay = 0.05 and P value to remove = 0.10) was used to select variables to be included in the final model for each data collection. The Hosmer and Lemeshow test was used to evaluate goodness-of-fit for the logistic model. Statistical analyses were performed with SAS Version 8.2 (31). 
Results

Discussion
The NLSCY is the first population-based Canadian national survey to document characteristics of young children who use MPH. The survey data confirm that the prevalence of MPH use among Canadian children aged 2 to 11 years was low and remained less than 2% from 1994-1995 until 1998-1999, a prevalence rate similar to that documented in the US during the same time period (5, 6, 8, 32) . As in other surveys of stimulant use (5-9,11,12,32) more boys than girls, and school children rather than preschoolers, used the medication. Over the 4-year follow-up period for the study, MPH use increased among girls and among those aged 6 to 11 years, findings consistent with other reports (6, 8) . In contrast to Zito and others' 2000 report (13), we obtained no evidence to suggest that use increased among preschoolers. However, few direct comparisons can be made with studies using administrative or prescription databases. An important aspect of our study is that information came directly from parents. Such self-report All children aged 2 to 11 years included in this table n weighted number, all weighted numbers rounded to the nearest 100 P value, chi-square test for comparison among correlates in 1994-1995, 1996-1997, and 1998-1999 information likely reflects actual health practices rather than physician recommendations or prescriptions.
The national prevalence of MPH use documented here is somewhat higher than the 0.89% documented in Manitoba in 1995-1996 (9) and the 1.1% documented in British Columbia in 1996 (11) according to prescription databases of children aged 19 years and under. It is somewhat less than the 3.4% documented among Ontario adolescents by self-report of students in Grades 7 to 13 in 1997 (33) . These other Canadian studies cannot be directly compared with the current survey, owing to differences in methodology, target samples, and years of data collection. However, as documented elsewhere (5, 7, 9, 12) , levels of stimulant use may vary depending on geographic location.
The current data analysis additionally clarifies previous findings from the NLSCY database that MPH use among Canadian children increased from 1994-1995 to 1996-1997 (21). The 4-year follow-up data reported here provide more clarity regarding the extent of increased use. More important, parent reports of child behaviours were measured in addition to age and sex, confirming that childhood hyperactivity is an important correlate of MPH use among Canadian children. Moreover, the strength of the association between parent-reported hyperactivity and stimulant use increased over the 4-year follow-up period. MPH use was also associated with male sex and school age (that is, age 6 to 11 years) at all 3 data collections. This finding supports other studies suggesting that increased MPH use in the mid-1990s occurred among those children at risk for ADHD (8) . Without information from teachers, the data collected here cannot answer questions regarding the match between ADHD diagnosis and stimulant use for individual children. Even so, this estimate of MPH use remains well below published estimates of the disorder (1, 34) . This information suggests that there is little cause for concern about widespread overuse of stimulants.
Our study identified only one parent characteristic in each of the 3 logistic regression models associated with MPH use in children: parental alcohol use was negatively correlated with MPH use. This may be a crude measure of parental health practice; that is, families where parents drink alcohol on a regular basis may be less likely to address a child's health care All children aged 2 to 11 years included in this table n weighted number; all weighted numbers rounded to the nearest 100 P value, chi-square test for comparison among correlates *P < 0.05, **P < 0.01, *** P < 0.001 Suppressed = data suppressed owing to unacceptable coefficient of variation > 33.3%
needs. Across the 3 data collections, other measures of parental mental health, (for example, maternal depression), of health practices (for example, parental smoking) and of overall family functioning or parenting practices (for example, aversive parenting) showed no consistent association with the child's use of stimulants.
The NLSCY database offers a lens through which to view the changes in prevalence of stimulant use for children with ADHD that differs from the view offered by administrative or prescription databases. The emphasis here is on the population of all Canadian children, most of whom are healthy and never take prescriptions. Children identified in administrative or prescription databases are those brought to health care professionals. These differences in sample characteristics as well as information source alter the "magnification" with which the issue of stimulant use is examined. Here, parent-reported stimulant use among school children aged 6 to 11 years increased by 25% from 1994-1995 to 1998-1999, while the overall use remained low at less than 3%.
Limitations
Conclusions drawn from the current study are limited by the study design necessitated by the logistic challenges of large population-based surveys. Specifically, the need to rely on substitute markers for ADHD diagnosis and stimulant treatment and the need to rely solely on parental reports, without access to teacher reports, limit the interpretation of the results.
It could be asked whether some children were taking stimulant medication and were therefore no longer symptomatic, possibly leading to an underestimation of the association between medication use and hyperactivity. Standard clinical practice during the 1990s was for children to take stimulants targeted to improve behaviour at school but not at home. On such dosage schedules, children are symptomatic at home, even when they are not symptomatic at school (35) . Therefore, parent ratings are likely to reflect ongoing hyperactivity and inattention.
The characteristics of the samples changed over time, with the initial sample being less urban, less well educated, and having lower income adequacy than the third sample. However, while these demographic factors are potential markers of access to health care, they were not highly associated with MPH use, and therefore, the variation in sample characteristics does not interfere with the conclusions drawn from the regression models. As an additional precaution against biased results, we have chosen to report only the associations of MPH use that were significant in all 3 models. 
Summary
Between 1994-1995 and 1998-1999, MPH use was low among Canadian children aged 2 to 11 years, the prevalence remaining less than 2%. Some increase in use occurred among girls and school-aged children (that is, aged 6 to 11 years). Child characteristics of parent-reported hyperactivity, male sex, and school age were important correlates of MPH use. 
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